Immunometabolism in Health and Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunometabolism in Health and Disease

Published:2022-10 Issue:12 Volume:22 Page:1147-1148
ISSN:1871-5303
Container-title:Endocrine, Metabolic & Immune Disorders - Drug Targets
language:en
Short-container-title:EMIDDT

Author:

Doroudchi Mehrnoosh¹²³,Kalantar Kurosh¹²⁴

Affiliation:

1. Department of Immunology School of Medicine, Shiraz University of Medical Science, P.O.Box: 71345-3119 Postal code: 71348-45794 Shiraz-Iran

2. Immunology Center for Excellence, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

3. Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

4. Autoimmune Disease Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference7 articles.

1. Vakili M.E.; Saleh Z.; Kabelitz D.; Kalantar K.; Targeting citrate carrier (CIC) in inflammatory macrophages as a novel metabolic approach in COVID-19 patients: A perspective. Endocr Metab Immune Disord Drug Targets 2022,22(12),1149-1153

2. Bakhtiari M.; Asadipooya K.; Metainflammation in COVID-19. Endocr Metab Immune Disord Drug Targets 2022,22(12),1154-1166

3. Al-Jabri Z.; Al-Reesi I.; Al-Shizawi N.; Al-Balushi M.S.; Al-Jabri A.A.; Said E.A.; Effects of bacterial metabolites on the immune system: enemies and friends. Endocr Metab Immune Disord Drug Targets 2022,22(12),1167-1177

4. Sarabi M.M.; Babaeenezhad E.; Amini M.; Kaviani M.; Naghibalhossaini F.; Bilirubin and epigenetic modifications in metabolic and immunometabolic disorders. Endocr Metab Immune Disord Drug Targets 2022,22(12),1178-1190

5. Babaahmadi-Rezaei H.; Rezaei M.; Ghaderi-Zefrehi H.; Azizi M.; Beheshti-Nasab H.; Mehta J.L.; Reducing proteoglycan synthesis and nox activity by rock inhibitors: Therapeutic Targets in Atherosclerosis. Endocr Metab Immune Disord Drug Targets 2022,22(12),1191-1200

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3